Most bought healthcare stocks in Q1 2011

See which Healthcare stocks institutional investors increased the most in Q1 2011, measured as net growth in reported share positions from Q4 2010 into Q1 2011. Notable additions at the top of this list include JOHNSON & JOHNSON (JNJ), MERCK & CO. INC. (MRK), ABBOTT LABORATORIES (ABT), PFIZER INC (PFE). These rankings aggregate SEC 13F filings from all institutional investors in our database.

Explore more:

Net change in reported shares (all institutional filers) by symbol5 symbols with net change in reported shares from all institutional filers.0.00155.6K311.2K466.7K622.3KNet change in reported shares (all institutional filers)JNJMRKABTPFELLYSymbol
SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
JNJJOHNSON & JOHNSON565,749$28.75M02002
MRKMERCK & CO. INC.451,574$11.13M02002
ABTABBOTT LABORATORIES148,800$8.40M01001
PFEPFIZER INC99,800$7.97M02002
LLYELI LILLY & CO4,625$166.59K01001

Frequently asked questions about Most bought healthcare stocks in Q1 2011

  • What are the most bought Healthcare stocks in Q1 2011?

    The most bought healthcare stocks in Q1 2011 are those with the largest increase in reported share counts across institutional investors compared to Q4 2010, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q1 2011?

    Among filers in this sector, net additions were largest in companies such as JOHNSON & JOHNSON (JNJ), MERCK & CO. INC. (MRK), ABBOTT LABORATORIES (ABT), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2010).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.